NR1H4 and metabolic dysfunction-associated steatotic liver disease: Rh4 can modulate hepatic and intestinal bile acid metabolism, lipid metabolism, and inflammatory factor-related phenotypes in the liver through the FXR signaling pathway, leading to the therapeutic effects on NAFLD.